Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial
Titel:
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial
Auteur:
Lazzarin, Adriano Campbell, Thomas Clotet, Bonaventura Johnson, Margaret Katlama, Christine Moll, Arend Towner, William Trottier, Benoit Peeters, Monika Vingerhoets, Johan de Smedt, Goedele Baeten, Benny Beets, Greet Sinha, Rekha Woodfall, Brian